AzTrials
AzTrials

FrailtyNCT04650789

Longitudinal Study of Frailty in Shanghai Older People

An observational study of Frailty, run by Shanghai University of Traditional Chinese Medicine at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To investigate the prevalence of Frailty in community older residents. Read more about this study

Who is it for?
Ages 65 to 85 yearsHealthy volunteers can take part
Conditions the study is for
Frailty
How many people
6,000 participants
Where
1 siteChina
Study dates
1 Jan 2018to 31 Dec 2021
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 to 85 years
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Study population: Cluster random sampling was used in urban and rural areas of Shanghai

Who may be able to join

  • more than 65 years old
  • Permanent residence in Shanghai and long-term residence in the community implemented by this project (more than five years)
  • Be willing to and be able to join in the study and signed Informed consent.

Who cannot join

  • Excluding the patients whose physical function is affected by diseases or disabilities such as stroke, Parkinson's disease, tumor, fracture, etc.
  • Excluding schizophrenia, depression, anxiety and other mental diseases and dependent on drug control.
  • If they were unable to complete the study survey.
  • Unwilling to join in the study and don't sign Informed consent.

Trial locations and contacts

1 site in 1 country.

China1 site, 1 recruiting
  • Shanghai Geriatric Institute of Chinese Medicine

    Shanghai, Shanghai Municipality, 200000

    Chuan Chen, 86-21-64720010, ch9453@126.com

    Recruiting

Other trials in China

About this study

To investigate the prevalence of Frailty in community older residents.

Read the detailed description

Detailed Description:

  1. Objective:
  • To investigate the prevalence of Frailty in community older residents.
  • To explore the causes and risk factors of frailty.
  1. Method:
  • The survey is a Community-based, multicenter prospective cohort study. 1). 6,000 participants are expected to be included.
  • Through a questionnaire and physical examination form, carries on the investigation to the more than 65 years old people during the 3-year follow-up period.
  • The questionnaires include survey date, participant characteristics and related risk factors, such as comprise demographic characteristics, Chinese ethnic nationality, marital status, education level, family incomes, occupation, pregnancy and parity history, menstrual history, frequency and amount of daily smoking and alcohol drinking, frequency of urination and defecation, dietary habits, hours per day of sleep and sun exposure. Medical history including medication use and disease status for comorbidities, will be obtained from participants' medical records. Syndrome differentiation of deficiency of the five zang-organs in TCM will be analyzed.
  • Height and body weight will be measured for body mass index (BMI) calculation. The waist circumference and hip circumference will be recorded, and the ratios calculated. The muscle strengths of both hands will be measured with a hand dynamometer. Each of these measures will be assessed twice and the average score used in analyses.
  • Subjects will be asked to walk a distance of 4 meters and record the time at the same time to measure the walking speed.
  • Clock Drawing Test (CDT), physical frailty examination, Mini-Mental State Examination (MMSE), Skeletal muscle mass index (SMI) will also be conducted or calculated .
  • Each participant will provide a total of 7 mL of venous blood after an overnight fast (10-hour).

After being collected, markers of frailty will be measured, such as Interleukin-6 (IL-6), insulin-like growth factor-1 (IGF-1) and estrogen (E). And blood routine, urine routine, liver and kidney function, fasting plasma glucose, serum lipid will be detected.

  • Physicians in each community as the backbone, Shanghai Geriatric Institute of Chinese Medicine is responsible for personnel training.
  • Shanghai community health service centers are responsible for organization and coordination.
Conditions
Frailty
Keywords
Frailty, Longitudinal cohort study, prevalence
Medical subject headings
Frailty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The level of frailty

    1. Unexpected significant weight loss(>5%).
    2. Decreased strength: male grip strength ≤25 kg and female grip strength ≤18 kg
    3. Reduced physical activity in the last month.
    4. Slow walking speed is less than or equal to 0.8 m/s.
    5. How tired you feel for the last month? The frailty period was defined as ≥3 items, early frailty was defined as 1-2 items, and non-frailty was defined as 0 items.

    Measured: baseline

Secondary outcomes (5)
  1. Clock Drawing Test

    The subjects were scored on a four-point scale by drawing a clock face on a piece of white paper.

    Measured: baseline

  2. Mini-Mental State Examination (MMSE)

    Two or three points in the drawing clock test were measured using the MMSE.

    Measured: baseline

  3. Skeletal muscle mass index (SMI)

    The ratio of skeletal muscle weight to height squared was measured by DXA.

    Measured: baseline

  4. Markers of frailty

    Markers of frailty, such as Interleukin-6 (IL-6), insulin-like growth factor-1 (IGF-1) and estrogen (E).

    Measured: baseline

  5. Routine inspection

    Fasting peripheral blood collected 4ml. blood routine, urine routine, liver and kidney function, fasting plasma glucose, serum lipid.

    Measured: baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Dec 2020
  2. Study start1 Jan 2018
  3. Primary completion31 Dec 2021 (estimated)
  4. Study completion31 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
6,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04650789
Sponsor's protocol ID
Shanghai Frailty Survey
Status last verified
May 2020
First submitted
24 Aug 2020
Last updated
3 Dec 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Frailty, run by Shanghai University of Traditional Chinese Medicine at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 3 Dec 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Chuan Chen (86-21-64720010, ch9453@126.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The level of frailty (time frame: baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Dec 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in